Skip to content

Cell assissted lipotransfer

Evaluation of fat grafted stability in cell assisted lipotransfer method in patients with facial atrophy

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT201612291031N21
Enrollment
10
Registered
2017-01-01
Start date
2015-11-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin atrophy. Atrophic disorder of skin, unspecified

Interventions

Intervention: transplantation of cell enriched fat with cannula number 20, 40-60 ml, single dose.
Treatment - Other
Intervention: transplantation of cell enriched fat with cannula number 20, 40-60 ml, single dose

Sponsors

Royan Institute
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age older than 20 years old; facial atrophy; female gender. Exclusion criteria: pregnancy or lactating; patients with active disease; infection at the recipient/donor site; use of immunosuppressive and cytotoxic drugs at least for past 6 months; underline chronic disease; history of biologic or synthetic filler; history of lipotransfer.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Safety of the intervention. Timepoint: 3, 6 and 12 months after transplantation. Method of measurement: Patients history.

Secondary

MeasureTime frame
Percentage of fat grafted stability. Timepoint: 3, 6 and 12 months after transplantation. Method of measurement: Physician assessment.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Bajouri

Royan Institute

bajouri_md@yahoo.com+98 21 2251 8388

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026